Keywords: topical, impotence, drug, promising, macrochem, announced, response

Topical Impotence Drug Promising

Article | 26 June 1997

MacroChem has announced a 67%-75% response rate to its topicaltreatment for male erectile dysfunction, SEPA/alprostadil, in a 48-patient study. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Alprostadil

Prostin VR Pediatric

Go to drug listing